1. Home
  2. TECH vs FCNCP Comparison

TECH vs FCNCP Comparison

Compare TECH & FCNCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TECH
  • FCNCP
  • Stock Information
  • Founded
  • TECH 1976
  • FCNCP N/A
  • Country
  • TECH United States
  • FCNCP United States
  • Employees
  • TECH N/A
  • FCNCP 16021
  • Industry
  • TECH Biotechnology: Biological Products (No Diagnostic Substances)
  • FCNCP Major Banks
  • Sector
  • TECH Health Care
  • FCNCP Finance
  • Exchange
  • TECH Nasdaq
  • FCNCP Nasdaq
  • Market Cap
  • TECH 8.0B
  • FCNCP N/A
  • IPO Year
  • TECH 1989
  • FCNCP N/A
  • Fundamental
  • Price
  • TECH $50.50
  • FCNCP $20.88
  • Analyst Decision
  • TECH Buy
  • FCNCP
  • Analyst Count
  • TECH 8
  • FCNCP 0
  • Target Price
  • TECH $81.14
  • FCNCP N/A
  • AVG Volume (30 Days)
  • TECH 2.3M
  • FCNCP N/A
  • Earning Date
  • TECH 05-07-2025
  • FCNCP N/A
  • Dividend Yield
  • TECH 0.63%
  • FCNCP N/A
  • EPS Growth
  • TECH N/A
  • FCNCP N/A
  • EPS
  • TECH 0.98
  • FCNCP N/A
  • Revenue
  • TECH $1,196,016,000.00
  • FCNCP N/A
  • Revenue This Year
  • TECH $8.19
  • FCNCP N/A
  • Revenue Next Year
  • TECH $8.61
  • FCNCP N/A
  • P/E Ratio
  • TECH $51.54
  • FCNCP N/A
  • Revenue Growth
  • TECH 4.46
  • FCNCP N/A
  • 52 Week Low
  • TECH $46.44
  • FCNCP N/A
  • 52 Week High
  • TECH $85.57
  • FCNCP N/A
  • Technical
  • Relative Strength Index (RSI)
  • TECH 41.82
  • FCNCP 51.01
  • Support Level
  • TECH $49.15
  • FCNCP $19.54
  • Resistance Level
  • TECH $51.53
  • FCNCP $20.78
  • Average True Range (ATR)
  • TECH 2.64
  • FCNCP 0.29
  • MACD
  • TECH 0.44
  • FCNCP 0.17
  • Stochastic Oscillator
  • TECH 54.03
  • FCNCP 92.42

About TECH Bio-Techne Corp

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.

About FCNCP First Citizens BancShares Inc.

First Citizens BancShares Inc is the bank holding company of First Citizens Bank & Trust Company. FCB was founded as the Bank of Smithfield in North Carolina and has expanded through both de novo branching and acquisitions. FCB currently operates in nearly half of the continental United States, but principally takes deposits in the Carolinas. The bank's operations have historically been influenced by the Holding family, which has traditionally held executive and director positions, as well as controlling a large percentage of its outstanding stock. FCB provides a wide range of retail and commercial banking services, including traditional lending and deposit-taking, as well as trust and wealth management. FCB's main source of revenue is net interest income.

Share on Social Networks: